Stock comparison
JOHNSON & JOHNSON is 70.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($618.03 B vs $8.82 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 70.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($618.03 B vs $8.82 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 70.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($618.03 B vs $8.82 B).
Revenue leader
JNJ
CRNX: $7.70M vs JNJ: $94.19B.
Profit leader
JNJ
CRNX: -$465.30M vs JNJ: $26.80B.
Margin leader
JNJ
CRNX: -6046.0% vs JNJ: 28.5% net margin.
| Metric | CRNX | JNJ |
|---|---|---|
| Market cap | $8.82 B | $618.03 B |
| US-listed rank | #1034 | #18 |
| Revenue (latest FY) | $7.70M | $94.19B |
| Net income (latest FY) | -$465.30M | $26.80B |
| Net margin | -6046.0% | 28.5% |
| P/E (trailing FY) | - | 23.1x |
| SEC filings | 670 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 70.1x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($618.03 B vs $8.82 B).
In their latest fiscal years, Crinetics Pharmaceuticals, Inc. reported $7.70M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Crinetics Pharmaceuticals, Inc. and JOHNSON & JOHNSON, or browse the full rankings.